Skip to content
€210.00
CJC-1295 (No DAC) is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH 1-29), designed to stimulate the pituitary’s natural growth hormone secretion through transient receptor activation. The “No DAC” means this version does not contain the Drug Affinity Complex modification.
Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist that acts synergistically with GHRH analogues. When combined, CJC-1295 (No DAC) and Ipamorelin are studied for their complementary stimulation of the GH axis through independent receptor pathways.
CJC 1295 No Dac (5mg) + Ipamorelin (10mg) Blend Calculation:
Examples of calculated units per pen of CJC 1295 No DAC (5 mg) + Ipamorelin (10 mg) – BLEND corresponding to micrograms:
1 unit = 16.7 mcg CJC No DAC and 33.3 mcg Ipamorelin;
3 units = 50.0 mcg / 100.0 mcg;
6 units = 100.0 mcg / 200.0 mcg;
9 units = 150.0 mcg / 300.0 mcg
Ipamorelin+CJC Certificate of Analysis
Storage and Shipping Guidelines
MADE IN EUROPE. Products from this Web Site are NOT intended to be used to diagnose or treat any medical condition or disease. Products on this website are sold for laboratory research purposes only and are for in-vitro lab research use only.
The products are not medicines or drugs and they have not been approved by the FDA to prevent, treat, diagnose, mitigate, or cure any disease, ailment or medical condition.
In stock
Disclaimer: For Research Purposes Only
This content is provided strictly for research purposes and does not constitute an endorsement or recommendation for the non-laboratory application or improper handling of peptides designed for research. The information, including discussions about specific peptides and their researched benefits, is presented for informational purposes only and must not be construed as health, clinical, or legal guidance, nor an encouragement for non-research use. Peptides described here are solely for use in structured scientific study by authorized individuals. We advise consulting with research experts, medical practitioners, or legal counsel prior to any decisions about obtaining or utilizing these peptides. The expectation of responsible, ethical utilization of this information for legitimate investigative and scholarly objectives is paramount. This notice is dynamic and governs all provided content on research peptides.
OR
